PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 36 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2018. The put-call ratio across all filers is 3.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $635,000 | – | 658,826 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 210,000 | $502,000 | 0.09% |
| SEARLE & CO. | 13,325 | $32,000 | 0.02% |
| Cetera Investment Advisers | 46,750 | $112,000 | 0.02% |
| Virtu Financial LLC | 46,610 | $111,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 79,921 | $191,000 | 0.00% |
| Renaissance Technologies | 941,250 | $2,250,000 | 0.00% |
| NORTHERN TRUST CORP | 12,435 | $29,000 | 0.00% |
| Avior Wealth Management, LLC | 70 | $0 | 0.00% |
| UBS Group AG | 6,516 | $16,000 | 0.00% |
| Stratos Wealth Partners, LTD. | 5 | $0 | 0.00% |